Upload
Featured Recent Articles Topics Login Upload

Search Results for 'disease drug'

disease drug published presentations and documents on DocSlides.

Orphan Drug Global Incentives & Regulatory Framework
Orphan Drug Global Incentives & Regulatory Framework
by pasty-toler
Marlene E. Haffner, MD, MPH. CEO, Haffner Associ...
Robert Plenge, MD, PhD The Role of Human Genetics in Drug Discovery
Robert Plenge, MD, PhD The Role of Human Genetics in Drug Discovery
by jones
Why do drugs fails?. …now it is efficacy/safety....
Addiction as Disease Crime and Treatment
Addiction as Disease Crime and Treatment
by ellena-manuel
Man as Automaton. Neil A Kurtzman, MD. Internal M...
Disease Modifying Anti-rheumatic Drugs
Disease Modifying Anti-rheumatic Drugs
by pagi
“DMARDs”. Objectives:. Important. . Notes....
Drug-Induced Liver Injury
Drug-Induced Liver Injury
by liane-varnes
Soheil Altafi MD. 1/27/15. DILI- Table of Content...
Leveraging omics data in drug development
Leveraging omics data in drug development
by trish-goza
– . get ready for the show. Weidong Zhang. Pfiz...
Drug Use, Misuse and Residues
Drug Use, Misuse and Residues
by pasty-toler
Learning objectives. Know advantages and disadvan...
Drug Residue Avoidance in Swine
Drug Residue Avoidance in Swine
by myesha-ticknor
Swine Industry. The swine industry . is a vertica...
The Pharmaceutical Industry and The Process of Drug Discovery
The Pharmaceutical Industry and The Process of Drug Discovery
by luanne-stotts
What is a Drug?. Types of Pharmaceutical Products...
Ataxia Drug Treatments: Targets and Pipeline
Ataxia Drug Treatments: Targets and Pipeline
by singh
Susan L. Perlman M.D.. Clinical Professor of Neuro...
Human genetics and drug discovery:
Human genetics and drug discovery:
by HappyHippie
the future is now. Robert Plenge, MD, PhD. Broad I...
Liposome-based synergy strategies for effective drug delivery across the BBB as a novel treatment f
Liposome-based synergy strategies for effective drug delivery across the BBB as a novel treatment f
by christina
Alzheimer's Disease (AD). Alzheimer's disease (AD)...
Should I Use a DCB (Drug Coated Balloon) Here?
Should I Use a DCB (Drug Coated Balloon) Here?
by mackenzie
Brandon M. Jones, MD. Interventional Cardiology. P...
Lecture 1 Introduction to Drug Discovery
Lecture 1 Introduction to Drug Discovery
by zoe
1. Dr. Abd El Raheim Donia. Generally,. . a drug ...
Sickle Cell Vascular Disease Section, Cardiovascular Pulmon
Sickle Cell Vascular Disease Section, Cardiovascular Pulmon
by yoshiko-marsland
EXAMINING PREVALENCE OF TOBACCO,. ALCOHOL, ILLICI...
1 Batten animal research Network :Lincoln NZ
1 Batten animal research Network :Lincoln NZ
by pasty-toler
. Finnish and Variant Late Infantile Batten Dise...
Going Beyond the Current Regulatory and Incentives Framewor
Going Beyond the Current Regulatory and Incentives Framewor
by calandra-battersby
A new proposal to foster greater orphan drug deve...
Do medications such as isoniazid and methyldopa, nitrofuran
Do medications such as isoniazid and methyldopa, nitrofuran
by celsa-spraggs
By Sheila Mulhern. Understanding Drug Metabolism....
PPharm
PPharm
by ellena-manuel
Projects. Molecular Mechanism of Drug Action and...
Lessons Learned from Sovaldi -
Lessons Learned from Sovaldi -
by tawny-fly
The Future is NOW in Specialty Pharmacy. August, ...
The Small Ubiquitin-like Modifiers: Established and emergin
The Small Ubiquitin-like Modifiers: Established and emergin
by kittie-lecroy
diseases. Mike Tatham. Ron Hay lab. Wellcome Trus...
October RDLA Lunch Meeting/Webinar
October RDLA Lunch Meeting/Webinar
by tawny-fly
Oct. 16th, 2014. The National Association of Insu...
Addiction is a brain disease: Meanings for the anesthesia community
Addiction is a brain disease: Meanings for the anesthesia community
by debby-jeon
Art Zwerling, DNP, CRNA, DAAPM. AANA PAAC. a.to.z...
MDR/XDR Tuberculosis and Atypical
MDR/XDR Tuberculosis and Atypical
by min-jolicoeur
Mycobacterial . Disease. . Increasing . Role for...
Extrapolation in Pediatric Drug Development: An Evolving Science
Extrapolation in Pediatric Drug Development: An Evolving Science
by briana-ranney
Lynne P. Yao, M.D.. Director, Division of Pediatr...
Chapter 44 Care of Patients with Problems of the Central Nervous System: The Brain
Chapter 44 Care of Patients with Problems of the Central Nervous System: The Brain
by celsa-spraggs
Headaches. Migraine headache. —. chronic, episo...
Human Immunodeficiency
Human Immunodeficiency
by alexa-scheidler
Virus (HIV) . Infection. Zoya. . Minasyan. RN-M...
Tuberculosis (TB) Basics
Tuberculosis (TB) Basics
by isabella2
With thanks to Adam Almeida, . Andolyn. Medina, a...
The next generation of genomicists
The next generation of genomicists
by WickedlyCool
Gerald J. Wyckoff. Training modes. Are we training...
Psychopharmacology in the Medically Ill
Psychopharmacology in the Medically Ill
by Dreamsicle
ACLP Resident Education Curriculum. Revised 2019: ...
Biomarker as essential part of clinical development
Biomarker as essential part of clinical development
by lauren
PhUSE 2014 Paper SP06 Renuka Chinthapally, Cytel S...
Pazopanib Interactions with FDA
Pazopanib Interactions with FDA
by claire
Office of Commissioner. Center for Drug. Evaulatio...
Appalling Adverse Effects of Amlodipine in a Chronic Kidney Disease Patient: A Case of Drug-Induced
Appalling Adverse Effects of Amlodipine in a Chronic Kidney Disease Patient: A Case of Drug-Induced
by caitlin
Geon . Pauly. , . Roopashri. Rajesh . Kashyap. , ...
RxPrep What is RxPrep? A company that offers online reviews for the NAPLEX and pharmacy law exams.
RxPrep What is RxPrep? A company that offers online reviews for the NAPLEX and pharmacy law exams.
by susan2
Since 2001, it has been the preferred study materi...
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
by walsh
Review article - Published online: 2021-04-13 . Th...
HAI/AR Collaborating Partners
HAI/AR Collaborating Partners
by tabitha
November 3, 2017. Old Business: Chapter 270: Hip...
Addiction: what is it & what can we do about it?
Addiction: what is it & what can we do about it?
by melanie
Shane Butler PhD. The Rational Ideal ? . The conce...
Repurposing Drugs for
Repurposing Drugs for
by franklin669
. Treatment. . of . Cardiovascular. . Disease. ...
Improving the process of rare disease treatment development
Improving the process of rare disease treatment development
by lindy-dunigan
“. EMERGING THERAPIES FOR RARE DISEASES. ”. ...
Addiction: A Chronic Brain Disease
Addiction: A Chronic Brain Disease
by celsa-spraggs
Flora Sadri, DO,MPH, FAAFP. Area Medical Director...